PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Department of Agriculture (USDA) has granted the company a license for CYTOPOINT™, the first monoclonal antibody ...
Cytopoint targets and neutralizes canine interleukin-31 (cIL-31), a key protein involved in triggering itch in dogs. Administered by injection once monthly, Cytopoint provides fast, long-lasting ...
* USDA granted license for CYTOPOINT, monoclonal antibody therapy approved to provide control of clinical signs associated with atopic dermatitis in dogs Source text for Eikon: Further company ...
If your eczema is making you itchy, your doctor might prescribe Dupixent, a Sanofi monoclonal antibody therapy with a U.S. list price of around $43,000 a year. If your dog Fritz’s eczema is making him ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results